GICS Sector : Healthcare
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States.It operates through three segments: Care Partners, Care Delivery, and Care Enablement.The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Astrana Health, Inc. reported a robust fourth quarter and full-year 2025 earnings, with total revenue reaching $950.5 million, a 43% year-over-year increase, and adjusted EBITDA of $52.5 million, up 50% year over year. For the full year, revenue hit $3.2 billion, with adjusted EBITDA totaling $205.4 million and non-GAAP adjusted EPS on a fully diluted basis at $2.20. The actual EPS came in at $0.1211, slightly below estimates of $0.15. The company's financial performance demonstrates stability and predictability, with a 34% compound annual growth rate in revenue since 2019.
Publication Date: Mar -03
The company's revenue growth is driven by sustained demand from payer and provider partners for coordinated, accountable care. Astrana Health is expanding its membership deliberately, with a focus on cultivating physician leadership and partnering with high-quality payers. The company's care enablement technology platform continues to drive operating leverage, enabling disciplined growth in new markets while expanding margins within existing businesses.
Analyzing Astrana Health's valuation metrics, we see a P/E Ratio of 57.62, indicating a relatively high valuation compared to its earnings. The P/S Ratio is 0.41, suggesting a reasonable valuation relative to its revenue. The EV/EBITDA ratio is 9.81, which is moderate. With an ROE of 2.93% and ROIC of 2.88%, the company's profitability is modest. The Net Debt/EBITDA ratio is -3.43, indicating a healthy debt position. Analysts estimate next year's revenue growth at 11.1%, which may impact the company's valuation multiples.
For 2026, Astrana Health expects continued revenue growth and adjusted EBITDA expansion, driven by growth across its core and expansion markets, ramping full-risk contracts, and realization of Prospect synergies. The company guides revenue in the range of $3.8 billion to $4.1 billion, adjusted EBITDA in the range of $285 million to $310 million, and free cash flow in the range of $150 million to $180 million. The guidance reflects a prudent planning framework, considering headwinds such as Medicaid and exchange disenrollments and adverse selection.
The integration of Prospect remains on track, with the company validating the strategic rationale for the transaction. The Care Enablement business is expected to operate at a 20-25% EBITDA margin range, with a strong pipeline for care enablement clients. The company's AI tools, including automated prior authorizations and claims processing, are expected to drive further G&A improvements and scalability in expansion markets.
Astrana Health, Inc. to Participate in Upcoming Investor Conferences
Mar -03
Astrana Health (NASDAQ:ASTH) Shares Gap Up After Earnings Beat
Mar -03
Astrana Health (ASTH) Surges on Strong Q4 Results and Optimistic Guidance
Mar -02
Astrana Health, Inc. (ASTH) Q4 2025 Earnings Call Transcript
Mar -02
Astrana Health, Inc. (ASTH) Q4 Earnings and Revenues Surpass Estimates
Mar -02
Astrana Health, Inc. Reports Fourth Quarter and Year End 2025 Results
Mar -02
Head to Head Comparison: Super Nova Resources (OTCMKTS:SNRR) & Astrana Health (NASDAQ:ASTH)
Feb -27
Astrana Health (NASDAQ:ASTH) versus Super Nova Resources (OTCMKTS:SNRR) Head to Head Analysis
Feb -08
Care Partners from Astrana Health, Inc. achieves 10% growth driven by increasing demand for value-based care, expansion into new markets, strategic partnerships, and investments in digital health technologies. Additionally, the company's focus on patient-centered care, cost-effective solutions, and strong provider networks contribute to its growth momentum.
Astrana Health's Care Delivery segment growth of 11% is driven by increasing adoption of value-based care models, expansion of Medicare Advantage and Medicaid managed care contracts, and strategic partnerships with healthcare providers to improve patient outcomes and reduce costs.
Astrana Health's Care Enablement segment growth of 13% is driven by increasing adoption of value-based care, rising demand for patient engagement platforms, and expansion into new markets. Additionally, the company's strategic partnerships, innovative care coordination solutions, and investments in AI-powered analytics are contributing to its rapid growth.
Astrana Health's 9% growth is driven by increasing demand for its innovative diagnostic solutions, strategic partnerships, and expansion into new markets. Additionally, the company's focus on digital health and AI-powered diagnostics has enabled it to capitalize on the growing trend of personalized medicine, further fueling its growth.
AstranaMD is a comprehensive telemedicine platform that enables remote consultations between patients and healthcare providers.
AstranaRx is a digital pharmacy platform that allows patients to manage their prescriptions and medications online.
AstranaCare is a care coordination platform that enables healthcare providers to manage patient care plans and coordinate care across different settings.
AstranaAnalytics is a data analytics platform that provides insights and analytics to healthcare providers and payers.
Astrana Health, Inc. has a moderate threat of substitutes due to the availability of alternative healthcare services and products.
Astrana Health, Inc. has a low bargaining power of customers due to the lack of concentration of buyers in the healthcare industry.
Astrana Health, Inc. has a moderate bargaining power of suppliers due to the presence of multiple suppliers in the healthcare industry.
Astrana Health, Inc. has a high threat of new entrants due to the growing demand for healthcare services and the ease of entry into the market.
Astrana Health, Inc. operates in a highly competitive industry with many established players, leading to a high intensity of rivalry.
| Value | |
|---|---|
| Debt Weight | 34.32% |
| Debt Cost | 7.79% |
| Equity Weight | 65.68% |
| Equity Cost | 9.52% |
| WACC | 8.93% |
| Leverage | 52.26% |
Value: 4.0
Growth: 7.8
Quality: 7.1
Yield: 0.0
Momentum: 4.5
Volatility: 6.7
1-Year Total Return ->
Value: 8.5
Growth: 6.2
Quality: 4.6
Yield: 0.0
Momentum: 6.5
Volatility: 3.3
1-Year Total Return ->
Value: 7.2
Growth: 3.7
Quality: 6.4
Yield: 8.0
Momentum: 0.5
Volatility: 2.7
1-Year Total Return ->
Value: 3.7
Growth: 6.4
Quality: 3.9
Yield: 0.0
Momentum: 8.5
Volatility: 1.0
1-Year Total Return ->
Value: 9.3
Growth: 4.6
Quality: 3.7
Yield: 0.0
Momentum: 1.0
Volatility: 4.7
1-Year Total Return ->
Value: 4.8
Growth: 5.9
Quality: 2.5
Yield: 0.0
Momentum: 0.5
Volatility: 2.3
1-Year Total Return ->